•  
  •  
  •  
  •  

2025-10-08 01:53:22

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
  • Revolt Motors fuels India's Racing Future with Sponsorship of Young Racer Ethan Joy at F4 India Championship
  • Simplex Realty Limited enters into supplemental agreement for redevelopment project
  • Ameenji Rubber Ltd. debuts on BSE SME Exchange
  • Mahanagar Gas Ltd signs MoU with Oil India Ltd to collaborate across the LNG value chain

Keywords Selected:  PGIMIndiaMutualFund

Research

  • Markets rebound despite tariff overhang - Vinay Paharia, CIO, PGIM India Mutual Fund
  • Global monetary easing to pick up pace - Puneet Pal, Head-Fixed Income, PGIM India Mutual Fund
  • We expect the 10 yr benchmark bond yield to keep drifting lower gradually - PGIM India Mutual Fund
  • Earnings growth should be the key driver of returns hereon - Vinay Paharia - CIO, PGIM India Mutual Fund
  • Bond Market Reaction from Union Budget 2024-25 by Puneet Pal, Head - Fixed Income , PGIM India Mutual Fund

Market Commentary

  • Great start to FY2026 - Debt Outlook by Puneet Pal, Head Fixed Income, PGIM INDIA Mutual Fund
  • Despite being the 4th largest economy India has one of the highest economic growths in the world - PGIM India MF

Latest Post

  • Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
  • Revolt Motors fuels India's Racing Future with Sponsorship of Young Racer Ethan Joy at F4 India Championship
  • Simplex Realty Limited enters into supplemental agreement for redevelopment project
  • Ameenji Rubber Ltd. debuts on BSE SME Exchange
  • Mahanagar Gas Ltd signs MoU with Oil India Ltd to collaborate across the LNG value chain


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024